Quest Diagnostics stock edges higher 1.76 percent as Quest Diagnostics celebrates National Logistics Day

Traders Union
All News
Companies
Quest Diagnostics up 1.76% today

Highlights

DGX sustains a strong bullish trend, trading well above key moving averages across all timeframes.
Momentum indicators signal overbought conditions and potential for short-term exhaustion despite persistent upward pressure.
DGX is projected to consolidate between $210.00 and $215.00, with the next resistance at the 52-week high of $213.50.

Sustained uptrend as price holds above key moving averages

DGX is trading at $209.88, well above the MA-20 ($199.44), MA-50 ($195.71), and MA-200 ($190.09), confirming a sustained bullish trend across short-, medium-, and long-term timeframes. The Ichimoku Kijun level on D1 stands at $199.38, acting as immediate support below the current price. Near-term support is located at the MA-20 ($199.44), with key support at the MA-50 ($195.71). Immediate resistance comes from the previous week’s high at $209.88, while the next key resistance is seen at the 52-week high of $213.50.

Overbought signals intensify as momentum fuels weekly rally

Momentum is strong, with MACD and ADX on D1 showing bullish sentiment. However, oscillators including RSI (66.73), Stoch RSI (100.00), CCI (153.71), and BBP (8.71) all indicate overbought conditions, signaling stretched upside and possible short-term exhaustion. BBP confirms overwhelming buyer dominance in intraday momentum, and the Awesome Oscillator also supports the bullish trend. DGX has risen $14.88 (7.63%) over the past week, opening from $195.00 and moving to the top of its weekly range—at weekly highs—with volatility standing at 8.8%. This marks a decisive rally and an extension move, as the price closes the week at the very top of its established range.

Upside probability high as consolidation hovers near resistance

Looking ahead, DGX is expected to trade between $210.00 and $215.00 over the next week. This keeps the price just below the 52-week high ($213.50) and well above the 52-week low ($164.65), reflecting a robust yearly uptrend. Based on bullish signals from RSI, ADX, MACD, and MA-50 on W1, the probability of further upside is very high (more than 80%), making a downside move much less likely. The baseline scenario foresees sideways consolidation just below recent highs. A bullish scenario would see DGX decisively break above $213.50, entering new highs. A bearish scenario requires a drop below the $199.44–$195.71 support cluster, triggering a reversal toward lower weekly levels.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that Quest Diagnostics was exhibiting a bullish structure supported by sustained trading above key technical levels. The current analysis affirms that this positive momentum remains intact, with traders advised to monitor for potential shifts should the stock approach significant support or resistance junctures.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.